Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 473

    1.

    Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.

    Pop-Busui R, Marinescu V, Van Huysen C, Li F, Sullivan K, Greene DA, Larkin D, Stevens MJ.

    Diabetes. 2002 Aug;51(8):2619-28.PMID: 12145179 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat.

    Stevens MJ, Lattimer SA, Feldman EL, Helton ED, Millington DS, Sima AA, Greene DA.

    Metabolism. 1996 Jul;45(7):865-72.PMID: 8692023 [PubMed - indexed for MEDLINE]Related articles

    3.

    Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.

    Pop-Busui R, Sullivan KA, Van Huysen C, Bayer L, Cao X, Towns R, Stevens MJ.

    Exp Neurol. 2001 Apr;168(2):259-72.PMID: 11259114 [PubMed - indexed for MEDLINE]Related articles

    4.

    Protein kinase C effects on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rats.

    Cameron NE, Cotter MA, Jack AM, Basso MD, Hohman TC.

    Diabetologia. 1999 Sep;42(9):1120-30.PMID: 10447525 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.

    Cameron NE, Cotter MA, Ferguson K, Robertson S, Radcliffe MA.

    Diabetes. 1991 Dec;40(12):1652-8.PMID: 1661693 [PubMed - indexed for MEDLINE]Related articles

    8.

    Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve.

    Coppey LJ, Davidson EP, Dunlap JA, Lund DD, Yorek MA.

    Int J Exp Diabetes Res. 2000;1(2):131-43.PMID: 11469397 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.

    Kumar S, Arun KH, Kaul CL, Sharma SS.

    Neurol Res. 2005 Jan;27(1):60-6.PMID: 15829161 [PubMed - indexed for MEDLINE]Related articles

    10.

    The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.

    Cameron NE, Cotter MA, Dines KC, Robertson S, Cox D.

    Br J Pharmacol. 1993 Aug;109(4):972-9.PMID: 8401950 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    NO- and non-NO-, non-prostanoid-dependent vasodilatation in rat sciatic nerve during maturation and developing experimental diabetic neuropathy.

    Thomsen K, Rubin I, Lauritzen M.

    J Physiol. 2002 Sep 15;543(Pt 3):977-93.PMID: 12231652 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes.

    Naka K, Sasaki H, Kishi Y, Furuta M, Sanke T, Nanjo K, Mukoyama M.

    Diabetes Res Clin Pract. 1995 Dec;30(3):153-62.PMID: 8861454 [PubMed - indexed for MEDLINE]Related articles

    14.

    Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters.

    Djemli-Shipkolye A, Coste T, Raccah D, Vague P, Pieroni G, Gerbi A.

    Cell Mol Biol (Noisy-le-grand). 2001 Mar;47(2):297-304.PMID: 11355004 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.

    Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA.

    Diabetes. 2000 Jun;49(6):1006-15.PMID: 10866054 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.

    Malone JI, Lowitt S, Corsico N, Orfalian Z.

    Int J Clin Pharmacol Res. 1992;12(5-6):237-41.PMID: 1301404 [PubMed - indexed for MEDLINE]Related articles

    17.

    Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine.

    Ido Y, McHowat J, Chang KC, Arrigoni-Martelli E, Orfalian Z, Kilo C, Corr PB, Williamson JR.

    Diabetes. 1994 Dec;43(12):1469-77.PMID: 7958501 [PubMed - indexed for MEDLINE]Related articles

    18.

    Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes.

    Lowitt S, Malone JI, Salem AF, Korthals J, Benford S.

    Metabolism. 1995 May;44(5):677-80.PMID: 7752919 [PubMed - indexed for MEDLINE]Related articles

    20.

    Metabolic effect of PGE1 analogue 01206.alpha CD on nerve Na(+)-K(+)-ATPase activity of rats with streptozocin-induced diabetes is mediated via cAMP: possible role of cAMP in diabetic neuropathy.

    Yasuda H, Maeda K, Sonobe M, Kawabata T, Terada M, Hisanaga T, Taniguchi Y, Kikkawa R, Shigeta Y.

    Prostaglandins. 1994 May;47(5):367-78.PMID: 8066185 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data